Tetomilast
- Generic Name
- Tetomilast
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18N2O4S
- CAS Number
- 145739-56-6
- Unique Ingredient Identifier
- S6RXB5KF56
- Background
Tetomilast has been used in trials studying the treatment of Crohn Disease, Colitis, Ulcerative, and Chronic Obstructive Pulmonary Disease.
- Indication
Investigated for use/treatment in ulcerative colitis.
- Associated Conditions
- -
- Associated Therapies
- -
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2009-04-02
- Last Posted Date
- 2017-04-17
- Target Recruit Count
- 84
- Registration Number
- NCT00874497
- Locations
- 🇺🇸
Los Angeles Biomedical Institute, Torrance, California, United States
🇺🇸Pulmonary Disease Specialist/PDS Research, Kissimmee, Florida, United States
🇺🇸Texas Institute of Chest and Sleep Disorders, PA, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath